Research Article
Volume 11 Issue 1 - 2022
Ionic Calcium in Blood as Early Marker of Severity in Patients with COVID-19
Jorge Chung Ching*
Pulmonologist, Arzobispo Loayza Hospital, Respiratory Medicine Service Lima, Perú
*Corresponding Author: Jorge Chung Ching, Pulmonologist, Arzobispo Loayza Hospital, Respiratory Medicine Service Lima, Perú.
Received: November 03, 2021; Published: December 29, 2021


The SARS CoV 2 pandemic has put health systems in serious trouble, especially in Peru, where resources are scarce. The situation is especially difficult for healthcare personnel who have to cope with a disease that is not yet well understood and for which there is no effective treatment. Many of the patients are usually underdiagnosed or misclassified in their state of severity due to the delay in reaching the sum of clinical, analytical and radiological criteria, delaying their treatment and worsening their prognosis. Many authors have reported the finding of low levels of total serum calcium and ionic calcium in severely compromised patients. The determination of ionic calcium has important comparative advantages over serum calcium because the quantification is carried out more quickly and safely, it is not affected by drugs or protein levels and very little by pH, factors that are usually present in COVID-19 patients. The present work ionic calcium in blood as early marker of severity in patients with covid-19 at the arzobispo loayza national hospital of Lima-Perú seeks to contribute to the knowledge showing that ionic calcium can be an early marker of severity in hospital emergency rooms severity, allowing a correct classification of the disease in less time, improving action protocols, saving material and human resources and above all saving valuable lives.

Keywords: Ionic Calcium; Blood; Patients; COVID-19; C-Reactive Protein


  1. “Coronavirus disease (COVID-19) Situation Report-113” (2020).
  2. Chen B., et al. “Overview of lethal human coronaviruses”. Springer Nature (2020): 5.
  3. Little P. “Non-steroidal anti-inflammatory drugs and covid-19”. BMJ 368 (2020).
  4. “COVID-19 Latin America and the Caribbean” (2020).
  5. Douedi S and Miskoff J. “Novel coronavirus 2019 (COVID-19)”. Medicine Baltimore19 (2020): e20207.
  6. Chen N., et al. “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study”. Lancet 395 (2020): 507-513.
  7. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet10223 (2020): 497-506.
  8. Wang D., et al. “Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China”. The Journal of the American Medical Association11 (2020): 1061-1069.
  9. Arentz M., et al. “Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State”. American Medical Association 323 (2020): 612-614.
  10. Leisman DE., et al. “Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes”. Lancet Respiratory Medicine (2020): 11
  11. Lippi G and Plebani M. “Laboratory abnormalities in patients with COVID-2019 infection”. Clinical Chemistry and Laboratory Medicine 58 (2020): 1131-1134.
  12. Lippi G and Plebani M. “Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis”. Clinica Chimica Acta 55 (2020): 190-191.
  13. Ministerio de Salud del Perú. RM 972-2020-MINSA. Manejo de personas afectadas COVID-19 en servicios de hospitalización (2020).
  14. Tenforde MW., et al. “Characteristics of Adult Outpatients and Inpatients with COVID-19 - 11 Academic Medical Centers, United States” 69.26 (2020): 841-846.
  15. Filippo L Di., et al. “Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19”. Endocrine 68 (2020): 475-478.
  16. Sun J-K., et al. “Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019: a retrospective cross-sectional study”. Aging12 (2020): 11287-11295.
  17. Liu J., et al. “Prevalence and predictive value of hypocalcemia in severe COVID-19 patients”. Journal of Infection Public Health 13 (2020): 1224-1228.
  18. Cappellini F., et al. “Low levels of total and ionized calcium in blood of COVID-19 patients”. Clinical Chemistry and Laboratory Medicine9 (2020): 171-173.
  19. Tenforde MW., et al. “Characteristics of Adult Outpatients and Inpatients with COVID-19 -11 Academic Medical Centers, United States” 69.26 (2020): 841-846.
  20. Myers LC., et al. “Characteristics of Hospitalized Adults with COVID-19 in an Integrated Health Care System in California”. Journal of the American Medical Association 323 (2020): 2195-2198.
  21. Cummings MJ., et al. “Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study”. Lancet10239 (2020): 1763-1770.
  22. Dillinger JG., et al. “Coronary Artery Calcification and Complications in Patients with COVID19”. Journal of the American College of Cardiology Imagining 11 (2020): 2468-2470.
  23. Stokes EK., et al. “Coronavirus Disease 2019 Case Surveillance -United States” 69.24 (2020): 759-765.
  24. Morris SB., et al. “Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection -United Kingdom and United States, March-August 2020”. Morbidity and Mortality Weekly Report 40 (2020): 1450-1456.
  25. Zhou F., et al. “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study”. Lancet10229 (2020): 1054-1062.
  26. Wu C., et al. “Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China”. JAMA Internal Medicine7 (2020): 934-943.
  27. Shi S., et al. “Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China”. JAMA Cardiology7 (2020): 802-810.
  28. Richardson S., et al. “Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area”. JAMA - The Journal of the American Medical Association 20 (2020): 2052-2059.
  29. Meyerowitz-Katz G and Merone L. “A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates”. International Journal of Infectious Diseases (2020): 101.
  30. Kurdi B., et al. “Mortality from Coronavirus Disease 2019 Increases with Unsaturated Fat and May Be Reduced by Early Calcium and Albumin Supplementation”. Gastroenterology3 (2020): 1015-1018.
  31. Rodriguez-Morales AJ., et al. “COVID-19 in Latin America: The implications of the first confirmed case in Brazil”. Travel Medicine and Infectious Disease 35 (2020): 101613.
  32. Weiss P and Murdoch DR. “Clinical course and mortality risk of severe COVID-19”. Lancet 395 (2020): 1014-1045.
Citation: Jorge Chung Ching. “Ionic Calcium in Blood as Early Marker of Severity in Patients with COVID-19”. EC Pulmonology and Respiratory Medicine 11.1 (2022): 03-09.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

July Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the July issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before July 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.